Adjuvant radiotherapy in postmenopausal women with early-stage ER-positive breast cancer: A systematic review and meta-analysis
Authors:
- Hanaa Abdelmoneim Mbbch KamelHKHanaa Abdelmoneim Mbbch Kamel
- Yehya KhlidjYKYehya Khlidj
- Dalal Salama Msc SalemDSDalal Salama Msc Salem
- Sara Adel Abdelkader Dpharm SaedSSSara Adel Abdelkader Dpharm Saed
- Khaled Msc AbouelmagdKAKhaled Msc Abouelmagd
- Dang Bs NguyenDNDang Bs Nguyen
- Emad Mbbch ShashESEmad Mbbch Shash
- Sanskriti ChapagainSCSanskriti Chapagain
- Loay KassemLKLoay Kassem
Open Access
- 21 February 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (8) , e41632
Abstract
Background: The management of early breast cancer (BC) includes breast-conserving surgery (BCS), postoperative radiation therapy (PORT) and systemic therapy. Therefore, we aim at evaluating all the efficacy endpoints for PORT compared to no PORT in older women with early-stage BC. Method: We searched PubMed, Web of Science, Cochrane, and Scopus databases from inception up to May 2024 for randomized controlled trials (RCTs) where patients were randomized into either PORT vs no PORT. The following outcomes were studied: any local recurrence, nodal recurrence, contralateral BC, distant relapse, all-causes and cancer-specific mortality. Result: Seven eligible RCTs with a total of 4860 patients were included; 2435 of them received PORT; and 2425 did not. All patients had a node-negative disease, with 84.4% older than 60 years and only 10.4% had tumors larger than 2 cm. Patients in both treatment arms were offered adjuvant endocrine therapy e.g. tamoxifen and anastrozole. The median follow-up was 9.7 years (95% CI: 5.1–11.3). The survival risk for any local recurrence for patients with no radiotherapy was significantly higher than for those who used PORT (HR: 6.3; 95% CI: 4.17–9.52). Also, patients in the PORT arm had a significantly lower risk of nodal recurrence (risk of recurrence (RR): 0.28, 95% CI: 0.11–0.72, P = .009). However, PORT was not associated with a significant reduction in the risk of contralateral BC, distant relapse, BC-specific mortality or all-cause mortality (RR: 0.883, 1.52, 1.12, 0.995, respectively). Conclusion: Postoperative radiotherapy significantly reduces local and regional recurrence following BCS in early estrogen receptor-positive elderly BC with limited value on distant recurrence or mortality. The risk-benefit ratio should be determined for every patient to avoid overtreatment of a significant proportion of patients.Keywords
This publication has 32 references indexed in Scilit:
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrenceEuropean Journal of Cancer, 2010
- Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Breast cancer incidence: what do the figures mean?Journal of Evaluation in Clinical Practice, 2005
- Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast CancerNew England Journal of Medicine, 2004
- Radiation therapy after breast-conserving surgeryEuropean Journal of Cancer, 2004
- Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: Radiation-induced lung toxicityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Prognostic Value of Histologic Grade and Proliferative Activity in Axillary Node–Positive Breast Cancer: Results From the Eastern Cooperative Oncology Group Companion Study, EST 4189Journal of Clinical Oncology, 2000